Upgrade to SI Premium - Free Trial

Precision BioSciences (DTIL)

6.50 +0.09 (1.40%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/7/26 *Est.)

Latest Headlines

Form 4 PRECISION BIOSCIENCES For: Jun 03 Filed by: Brown Melinda June 5, 2026 7:39 AM - SEC Filing Form 4 PRECISION BIOSCIENCES For: Jun 03 Filed by: Frankel Stanley June 5, 2026 7:38 AM - SEC Filing Form 4 PRECISION BIOSCIENCES For: Jun 03 Filed by: Germano Geno J June 5, 2026 7:37 AM - SEC Filing Form 4 PRECISION BIOSCIENCES For: Jun 03 Filed by: Pire Shari Lisa June 5, 2026 7:36 AM - SEC Filing Form 4 PRECISION BIOSCIENCES For: Jun 03 Filed by: Buehler Kevin June 5, 2026 7:35 AM - SEC Filing Form 4 PRECISION BIOSCIENCES For: Jun 01 Filed by: SMITH J. JEFFERSON June 3, 2026 4:07 PM - SEC Filing Form 4 PRECISION BIOSCIENCES For: Jun 01 Filed by: Scimeca Dario June 3, 2026 4:06 PM - SEC Filing Form 4 PRECISION BIOSCIENCES For: Jun 01 Filed by: Kelly John Alexander June 3, 2026 4:06 PM - SEC Filing Form 4 PRECISION BIOSCIENCES For: Jun 01 Filed by: Amoroso Michael June 3, 2026 4:05 PM - SEC Filing Form 8-K PRECISION BIOSCIENCES For: May 27 May 27, 2026 7:31 AM - SEC Filing Precision BioSciences reports hepatitis B gene therapy data from clinical trial May 27, 2026 4:05 AM - StreetInsider Precision BioSciences Announces New and Late-Breaking PBGENE-HBV Clinical Data from the ELIMINATE-B Study at European Association for the Study of the Liver Congress 2026 May 27, 2026 2:30 AM - BizWire Form 8-K PRECISION BIOSCIENCES For: May 21 May 26, 2026 5:20 PM - SEC Filing Form 4 PRECISION BIOSCIENCES For: May 20 Filed by: Buehler Kevin May 22, 2026 7:32 AM - SEC Filing Form 4 PRECISION BIOSCIENCES For: May 20 Filed by: Frankel Stanley May 22, 2026 7:31 AM - SEC Filing Form 4 PRECISION BIOSCIENCES For: May 20 Filed by: Brown Melinda May 22, 2026 7:31 AM - SEC Filing Form 4 PRECISION BIOSCIENCES For: May 20 Filed by: Pire Shari Lisa May 22, 2026 7:31 AM - SEC Filing Form 4 PRECISION BIOSCIENCES For: May 20 Filed by: Germano Geno J May 22, 2026 7:30 AM - SEC Filing Precision BioSciences to Host Investor Webcast to Discuss Late-Breaking PBGENE-HBV Data from ELIMINATE-B Trial Presented at European Association for the Study of the Liver Congress 2026 May 21, 2026 7:01 AM - BizWire iECURE reports positive results from gene therapy trial for rare disorder May 18, 2026 8:02 AM - StreetInsider iECURE Reports Sustained Clinical Response in the First Patient Dosed with ECUR-506 & Reductions in the Annualized Rates of Hyperammonemic Events and Crises in the First Completed Cohort of ECUR-5 May 18, 2026 8:00 AM - BizWire Precision BioSciences reports enhanced DMD gene therapy efficacy in younger mice May 14, 2026 7:01 AM - StreetInsider Precision BioSciences Presents New Preclinical Data Supporting the Advancement of PBGENE-DMD into Clinic at the American Society of Gene & Cell Therapy 2026 Annual Meeting May 14, 2026 7:01 AM - BizWire iECURE Presents Preliminary Clinical Data from Ongoing Clinical Trial of ECUR-506 in Ornithine Transcarbamylase Deficiency at the ASGCT Annual Meeting May 13, 2026 6:00 AM - BizWire Precision BioSciences (DTIL) Misses Q1 EPS by 75c May 5, 2026 10:22 AM - StreetInsider Form 10-Q PRECISION BIOSCIENCES For: Mar 31 May 5, 2026 7:20 AM - SEC Filing Form 8-K PRECISION BIOSCIENCES For: May 05 May 5, 2026 7:19 AM - SEC Filing Precision BioSciences Reports First Quarter 2026 Financial Results and Provides Business Update May 5, 2026 7:01 AM - BizWire Precision BioSciences to Report First Quarter 2026 Financial Results on May 5, 2026 April 30, 2026 7:01 AM - BizWire Precision BioSciences begins patient enrollment in DMD gene editing trial April 29, 2026 7:01 AM - StreetInsider Precision BioSciences Activates First Clinical Trial Site and Begins Patient Enrollment in Phase 1/2 FUNCTION-DMD Study April 29, 2026 7:01 AM - BizWire iECURE to Present Preliminary Clinical Data from Ongoing OTC-HOPE Trial of ECUR-506 in Neonatal-Onset Ornithine Transcarbamylase Deficiency at the ASGCT and SIMD Annual Meetings April 28, 2026 8:02 AM - BizWire Precision BioSciences to present DMD gene therapy data at ASGCT 2026 April 28, 2026 7:01 AM - StreetInsider Precision BioSciences Announces Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 2026 Annual Meeting April 28, 2026 7:01 AM - BizWire Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) April 24, 2026 7:01 AM - BizWire Precision BioSciences Announces Late-Breaking Poster Presentation for PBGENE-HBV at European Association for the Study of the Liver Congress 2026 April 22, 2026 7:01 AM - BizWire Jones Trading Assumes Precision BioSciences Inc. (DTIL) at Buy April 16, 2026 4:08 PM - StreetInsider Form SCHEDULE 13G/A PRECISION BIOSCIENCES Filed by: Empery Asset Management, LP April 15, 2026 9:46 AM - SEC Filing Precision BioSciences expands hepatitis B trial to France and Romania April 15, 2026 7:02 AM - StreetInsider Precision BioSciences Expands ELIMINATE-B Trial Following Clinical Trial Application Approval in Two European Countries April 15, 2026 7:01 AM - BizWire Form ARS PRECISION BIOSCIENCES For: Dec 31 April 8, 2026 7:02 AM - SEC Filing Form DEFA14A PRECISION BIOSCIENCES April 8, 2026 7:02 AM - SEC Filing Form DEF 14A PRECISION BIOSCIENCES For: May 21 April 8, 2026 7:01 AM - SEC Filing Precision BioSciences to Participate in the 25th Annual Needham Virtual Healthcare Conference April 8, 2026 7:01 AM - BizWire Form PRE 14A PRECISION BIOSCIENCES For: May 21 March 27, 2026 4:06 PM - SEC Filing Jones Trading stays Buy on Precision BioSciences Inc. (DTIL) following Ph1/2 trial design announcement March 18, 2026 9:07 AM - StreetInsider iECURE Selected for U.S. FDA Chemistry, Manufacturing, and Controls Development and Readiness Pilot Program to Support Manufacturing Readiness of ECUR-506 Ahead of Planned BLA Submission March 18, 2026 8:00 AM - BizWire Form 8-K PRECISION BIOSCIENCES For: Mar 17 March 17, 2026 8:32 AM - SEC Filing Precision BioSciences Inc. (DTIL) PT Lowered to $19 at Jefferies, but 'near-term setup is attractive' March 13, 2026 2:57 PM - StreetInsider Precision BioSciences (DTIL) Tops Q4 EPS by 105c March 12, 2026 8:36 AM - StreetInsider Form 10-K PRECISION BIOSCIENCES For: Dec 31 March 12, 2026 7:32 AM - SEC Filing Form 8-K PRECISION BIOSCIENCES For: Mar 12 March 12, 2026 7:31 AM - SEC Filing Precision BioSciences Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Business Update March 12, 2026 7:00 AM - BizWire Precision BioSciences receives patent allowances for HBV gene editing program March 11, 2026 7:01 AM - StreetInsider Precision BioSciences Receives U.S. Patent Allowances Covering the PBGENE-HBV Program March 11, 2026 7:01 AM - BizWire Precision BioSciences shows muscle improvements in DMD gene therapy study March 10, 2026 7:01 AM - StreetInsider Precision BioSciences Presents Preclinical PBGENE-DMD Data Highlighting Durable Dystrophin Expression and Functional Benefit at the Muscular Dystrophy Association Clinical & Scientific Conference March 10, 2026 7:01 AM - BizWire Precision BioSciences to Report Fourth Quarter and Fiscal Year 2025 Results on March 12, 2026 March 9, 2026 4:15 PM - BizWire Precision BioSciences gets FDA fast track for DMD gene therapy March 9, 2026 7:01 AM - StreetInsider Precision BioSciences Receives FDA Fast Track Designation for PBGENE-DMD and Announces Duchenne Muscular Dystrophy Investor Event March 9, 2026 7:01 AM - BizWire Full Article List